Zura Bio Limited
NASDAQ:ZURABiotechnology
Healthcare
$0.97 +1.93%
+$0.07 today
- Market cap
- $92.96M
- Beta
- 0.03
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$0.67
52W Low $1.00High $7.44
Volume 3.02M
Average 0.75M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$75.25M
FY 2025 · Annual
Net Income
-$68.65M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 0 | 23.69M | 44M | 24.4M | 42.08M |
| Selling, General & Admin | 1.09M | 3.47M | 18.64M | 30.79M | 33.16M |
| Operating Expenses | 1.09M | 27.16M | 62.64M | 55.19M | 75.25M |
| Depreciation & Amortization | 0 | 0 | 0 | 9K | 49K |
| EBITDA | 8.42M | (27.33M) | (60.56M) | (52.39M) | (68.6M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (1.09M) | (27.16M) | (62.64M) | (55.19M) | (75.25M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 23.48K | 570 | 2.19M | 8M | 6.34M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 9.51M | (171K) | 2.08M | 2.79M | 6.6M |
| Income Before Tax | 8.42M | (27.33M) | (60.56M) | (52.4M) | (68.65M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 8.42M | (25.74M) | (60.36M) | (52.4M) | (68.65M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 0.40 | 0.21 | (2.09) | (0.60) | (1.06) |
| EPS (Diluted) | 0.40 | 0.21 | (2.09) | (0.60) | (1.06) |
| 17.25M | 17.25M | 33.06M | 75.07M | 94.16M | |
| 17.25M | 17.25M | 33.06M | 75.07M | 94.16M |
ZURA Earnings Waterfall · TTM
NASDAQ:ZURA · Revenue to Net Income
Key Ratios
EPS$-1.09
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-5.3
P/S Ratio0.0
Analysis
$0 of revenue converted into -$75.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.09, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| EFFECT | EFFECT filing | Nov 3, 2026 | |
| S-3 | S-3 filing | Oct 27, 2026 | |
| 8-K | Current report | Oct 27, 2026 | |
| 10-Q | Quarterly report | Oct 27, 2026 |
How much revenue does ZURA generate?
Zura Bio Limited (ZURA) reported $0.00 of revenue in fiscal 2025.
Is ZURA profitable?
Zura Bio Limited (ZURA) reported -$68.65M of net income.
Continue the stock analysis
Jump to another research area for this company.